Sienna Biopharmaceuticals, Inc. Shareholders' Equity
Sienna Biopharmaceuticals, Inc. had Shareholders' Equity of $23.10 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2019-11-12
- 2019-09-30: Stockholders' Equity Attributable to Parent $23.10M.
- 2019-06-30: Stockholders' Equity Attributable to Parent $26.98M.
- 2019-03-31: Stockholders' Equity Attributable to Parent $33.29M.
- 2018-12-31: Stockholders' Equity Attributable to Parent $26.58M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2019-09-30 | $23.10M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $26.98M 10-Q · filed 2019-11-12 |
| 2019-03-31 | $33.29M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $26.58M 10-Q · filed 2019-11-12 |
| 2018-09-30 | $44.93M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $55.53M 10-Q · filed 2019-11-12 |
| 2018-03-31 | $76.42M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $91.20M 10-Q · filed 2019-11-12 |
| 2017-09-30 | $96.40M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $44.00M 10-Q · filed 2017-09-07 |
| 2016-12-31 | $22.12M 10-K · filed 2019-03-14 |
| 2015-12-31 | $4.05M 10-K · filed 2019-03-14 |
| 2014-12-31 | -$278.00K 10-K · filed 2018-03-15 |